R, M., M, C., L, B., AS, G., M, A., D, P., . . . Y, L. (2026). Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates. EBioMedicine, 129, 106361. https://doi.org/10.1016/j.ebiom.2026.106361
Chicago Style (17th ed.) CitationR, Marlin, et al. "Immunogenicity and Protective Efficacy on Non-adjuvanted CD40-targeting SARS-CoV-2 Vaccines in Non-human Primates." EBioMedicine 129 (2026): 106361. https://doi.org/10.1016/j.ebiom.2026.106361.
MLA (9th ed.) CitationR, Marlin, et al. "Immunogenicity and Protective Efficacy on Non-adjuvanted CD40-targeting SARS-CoV-2 Vaccines in Non-human Primates." EBioMedicine, vol. 129, 2026, p. 106361, https://doi.org/10.1016/j.ebiom.2026.106361.
Warning: These citations may not always be 100% accurate.